Ethics approval and consent to participate {24}
The trial is currently ongoing. The protocol was approved by the ethical committee board (CCER 2019–02469) in April 2020 and by ClinicalTrials.gov (Identifier: NCT04479397) in July 2020. All patients agree to participate, and a written consent will be obtained from all participants.